Latest round: Series B. Daniel Passeri is the President and CEO of Cue Biopharma, a biotechnology company focused on developing novel immunotherapies.
Daniel Passeri is the President and CEO of Cue Biopharma, a biotechnology company focused on developing novel immunotherapies for cancer and autoimmune diseases. He leads the company's strategic direction and operations as part of its executive leadership team.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide